The evidence points toward a combined approach: medication as one part of a broader plan that includes nutrition, movement, and professional support - not a standalone solution
Some clinicians prescribe phentermine as a bridge medication during GLP-1 transitions to maintain appetite suppression
The therapeutic effects of semaglutide stem from its high-affinity binding to GLP-1 receptors, which are G-protein-coupled receptors distributed throughout multiple organ systems
Nausea is the most common, with relative risk ratios of 2.69 at 4 mg, 4.27 at 8 mg, and 4.00 at 12 mg compared to placebo
Allergy to sitagliptin or any inactive ingredient Severe kidney disease or dialysis History of heart failure or pancreatitis Alcohol use, gallstones, high triglycerides Pregnancy or plans to become pregnant Breastfeeding or plans to breastfeed What drug interactions are there with Januvia
Prepare a summary of your medical history, current medications, and any previous weight loss attempts